Tambocor

   
Google
 
Web NewDrugInformation.com

Tambocor


Drug - Tambocor
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Flecainide Acetate
Multiple ingredients are in alphabetical order.

Strength - 100MG
The potency of the active ingredient(s), Flecainide Acetate. May repeat for multiple part products.

Applicant - 3M
The firm name holding legal responsibility for Tambocor. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018830
The FDA assigned number to Tambocor. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Tambocor. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 31, 1985
The date Tambocor was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Tambocor. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Tambocor is in. Format is RX, OTC, DISCN.

Applicant Full Name - 3m Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Tambocor.

Tambocor